Drive Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-339
| Closed | -$241K | – | 372 |
|
2024
Q4 | $241K | Sell |
339
-4
| -1% | -$2.85K | 0.06% | 262 |
|
2024
Q3 | $361K | Buy |
343
+11
| +3% | +$11.6K | 0.09% | 178 |
|
2024
Q2 | $349K | Buy |
332
+8
| +2% | +$8.41K | 0.09% | 175 |
|
2024
Q1 | $312K | Buy |
324
+13
| +4% | +$12.5K | 0.09% | 195 |
|
2023
Q4 | $273K | Buy |
311
+12
| +4% | +$10.5K | 0.09% | 208 |
|
2023
Q3 | $246K | Buy |
+299
| New | +$246K | 0.09% | 204 |
|
2023
Q2 | – | Sell |
-245
| Closed | -$201K | – | 309 |
|
2023
Q1 | $201K | Buy |
+245
| New | +$201K | 0.08% | 258 |
|